Mark G. Swain

Physics and Astronomy · Physical Sciences

75h-index20.8kcitations666works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Stellar, planetary, and galactic studies(171), Liver Disease Diagnosis and Treatment(154), Astronomy and Astrophysical Research(135), Liver Diseases and Immunity(122), Liver Disease and Transplantation(72)

Publications662 total

Diabetes and Obesity reduce FIB-4 accuracy in MASLD referral pathways
JHEP Reports·2026Open Access
CHAPITRE 8 LE FOIE
Les Presses de l'Université de Montréal eBooks·2025
Challenges facing the PBC community: insights from the PBC International Summit
Frontline Gastroenterology·2025Open Access
Barriers and facilitators to liver fibrosis screening: Perspectives and practices of Canadian primary care physicians
Canadian Liver Journal·2025Open Access
Call to action: integrating steatotic liver disease into public health strategies in Canada
The Lancet Regional Health - Americas·2025Open Access
The Atmospheric Composition of Sub-Neptune K2-18 b and Implications for its Formation
arXiv (Cornell University)·2025Open Access
Fatigue in Cholestatic Liver Disease: A Review of Mechanisms and Non-Pharmacological Management
Current Hepatology Reports·2025
P31 Elafibranor impacts inflammatory, fibrotic and symptom-associated markers in patients with primary biliary cholangitis (PBC): proteomic results from the ELATIVE trial
2025
P26 Elafibranor improves fatigue versus placebo in patients with primary biliary cholangitis (PBC), with limited correlation with pruritus: analyses from the phase III ELATIVE trial
2025
P36 Non-invasive tests for liver fibrosis are stable in patients with primary biliary cholangitis (PBC) with two years of treatment with elafibranor
2025
Global‐Scale Detection of Plastic From Space With the EMIT Imaging Spectrometer
Geophysical Research Letters·2025· 2 citedOpen Access
A review of multidisciplinary care in metabolic dysfunction‐associated steatohepatitis and cardiometabolic disease, with a focus on Canada
Diabetes Obesity and Metabolism·2025· 1 citedOpen Access
Long-term efficacy and safety of elafibranor in primary biliary cholangitis: Interim results from the open-label extension of the ELATIVE trial up to 3 years
Zeitschrift für Gastroenterologie·2025· 1 cited
Part 3: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Ultrasound Shear Wave Elastography and MR Elastography Program Implementation, Funding, and Quality Assurance
Canadian Association of Radiologists Journal·2025· 2 citedOpen Access
Part 1: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Guidance Statements for Detecting and Grading Hepatic Steatosis Using Ultrasound, CT, or MRI
Canadian Association of Radiologists Journal·2025· 3 citedOpen Access
Part 2: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Risk Stratifying Patients With MASLD
Canadian Association of Radiologists Journal·2025· 3 citedOpen Access
Building SPARCS, an ultraviolet science CubeSat for exoplanet habitability studies, technology advancements, and mission training
Journal of Astronomical Telescopes Instruments and Systems·2025Open Access
Building SPARCS, an Ultraviolet Science CubeSat for Exoplanet Habitability Studies, Technology Advancements, and Mission Training
ArXiv.org·2025Open Access
P199 Long-term efficacy and safety of elafibranor in primary biliary cholangitis: interim results from the open-label extension of the ELATIVE® trial
2025
Sex differences in the prevalence and cardiometabolic risk profiles of steatotic liver disease: A Canadian Longitudinal Study on Aging analysis
Canadian Journal of Public Health·2025· 4 cited
page 1 of 34Next →

Frequent Co-authors

G. Tinetti(8), Abdel Aziz Shaheen(6), Charlotte D’Mello(6), Gautam Vasisht(6), Gilaad G. Kaplan(5), Mitchell L. Shiffman(5), Robert P. Myers(5), Michael Trauner(5), J. Bouwman(5), John M. Vierling(5), Gideon M. Hirschfield(5), Pieter Deroo(4), C. A. Griffith(4), Christopher L. Bowlus(4), Michael A. Heneghan(4), Maureen N. Ajuebor(4), Kelly W. Burak(4), George Ν. Dalekos(4), Drake Deming(3), Ian J. M. Crossfield(3)